ARMATA PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
ARMATA PHARMACEUTICALS, INC. (ARMP) had Property, Plant and Equipment, Gross of $26.33 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-12
- 2026-06-30: Property, Plant and Equipment, Gross $26.33M.
- 2026-03-31: Property, Plant and Equipment, Gross $26.28M.
- 2025-12-31: Property, Plant and Equipment, Gross $26.23M.
- 2025-09-30: Property, Plant and Equipment, Gross $26.82M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $26.33M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $26.28M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $26.23M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $26.82M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $26.55M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $26.41M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $26.39M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $26.38M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $25.93M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $24.84M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $24.38M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $21.02M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $20.37M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $16.77M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $14.72M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $15.21M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $13.90M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $12.70M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $12.45M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $12.05M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $11.76M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $11.45M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $11.10M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $10.73M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $10.72M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $10.46M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $10.35M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $11.62M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $13.69M 10-Q · filed 2019-08-14 | |
| 2018-12-31 | $11.14M 10-K · filed 2020-03-19 | $2.03M 10-K · filed 2019-03-25 |
| 2017-12-31 | $1.99M 10-K · filed 2019-03-25 | |
| 2016-12-31 | $2.00M 10-K · filed 2018-03-14 | |
| 2015-12-31 | $1.74M 10-K · filed 2017-03-27 | |
| 2014-12-31 | $1.70M 10-K · filed 2016-03-30 | |
| 2013-12-31 | $496.00K 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |